Studies suggest vaccines cut long COVID symptoms Recent analysis from both the UK and Israel give positive signs for those with breakthrough infections, although Omicron is yet to be assessed.
Will an Omicron-specific vaccine help control COVID? A vaccine targeting the variant will increase immunity on both an individual and population level, but there’s a key problem.
COVID-19 chart updated with Omicron risk of death, benefits of boosters GPs can now access up-to-date data on the benefits of booster doses for patients who have received AstraZeneca as their primary course based on risks of Omicron transmission.
ATAGI rules on Novavax The long-awaited vaccine will be available from 21 February, but the RACGP has said general practice needs more support for the rollout.
How long should children wait to be vaccinated after COVID infection? COVID-19 vaccination for young children began at the same time as a spike in infections. Here is the most recent guidance available for GPs.
What causes long COVID? New Australian research has identified two proteins present in the body of those who report lingering symptoms post-infection.
Vaccination gap: Vulnerable communities left exposed as Omicron threatens Aboriginal and Torres Strait Islander COVID vaccination rates continue to lag the general population, with some areas still less than 50% fully vaccinated.
What are the symptoms of Omicron? As the virus has evolved, so too have the symptoms, writes Professor Tim Spector.
Is Omicron a greater threat to children than previous COVID variants? The new strain has widely been touted as the ‘milder COVID’, but more children are ending up in hospital than ever before.
In Practice: Valuable information for RACGP members The first edition for 2022 contains professional and clinical information directly relevant to general practice.